chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin normal, White blood cell count increased
Clinical narrative: Narrative: Pt reported blotchy red rash on upper extremities, hand shaking, sweating, and feeling of heart racing (HR 155) approximately 15 minutes after receiving first dose of Moderna COVID-19 vaccine. No SOB, throat swelling, itching. Reported some chest tightness but no pain. Symptoms resolved without treatment.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Hypersensitivity
Clinical narrative: Narrative:  Unclear exactly what happened, pt reported the allergy and symptoms about 2 weeks after COVID vaccine was administered. Per chart review, PCP also notes that pt was seen at ED and was found to have CHF so may be unrelated
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acidosis, COVID-19, Confusional state, Renal failure, SARS-CoV-2 antibody test
Clinical narrative: Narrative:  Patient was hospitalized due new onset renal failure with acidosis, confusion, and tremors, and then subsequently found to be COVID positive.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tremor
Clinical narrative: Narrative:  Patient was hospitalized due new onset renal failure with acidosis, confusion, and tremors, and then subsequently found to be COVID positive.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Narrative:  Patient called 3/31/21 (4 days) reporting symptoms after 2nd dose of COVID vaccine; patient advised to go to ER; pt went to outside facility and received antibiotic. Patient reported on 4/1/21 that symptoms have resolved and she feels much better.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cerebrovascular accident, Computerised tomogram head abnormal, Death, Mobility decreased
Clinical narrative: Narrative:  Patient had a stroke 18 hours after admission to the hospital which was 5.5 days after his second Pfizer vaccination. He had multiple stroke risk factors and was non-adherent with medications for 4-5 days prior to stroke, and poorly adherent prior to that. He was admitted to the hospital on 2/21/21 for an episode of weakness when going to the bathroom in the night on 2/20/21 and being unable to get up. Brought by ambulance to the hospital. Patient suffered another stroke while in rehab in April and passed away 4/24/21.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Condition aggravated
Clinical narrative: Narrative:  unrelated asthma history was triggered in clinic shortly after vaccine was administered monitored for 15 additional minutes after symptoms was self treated by her personal inhaler reported symptoms alleviated on their own and was released from clinic
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Chronic obstructive pulmonary disease, Death, Myocardial infarction, Resuscitation
Clinical narrative: Narrative:  77 yr-old male patient found unresponsive by wife in late evening of 2/26/21 (2 days following 2nd Moderna dose). Wife performed CPR until emergency help arrived however patient did not survive and was declared deceased on 2/27/21 at1212. Per death certificate, immediate cause of death "myocardial infarction" followed by longstanding of Afib and COPD. No autopsy reported. Of note, no ADR reported following 1st Moderna dose on 1/28/21.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Narrative:  77 yr-old male patient found unresponsive by wife in late evening of 2/26/21 (2 days following 2nd Moderna dose). Wife performed CPR until emergency help arrived however patient did not survive and was declared deceased on 2/27/21 at1212. Per death certificate, immediate cause of death "myocardial infarction" followed by longstanding of Afib and COPD. No autopsy reported. Of note, no ADR reported following 1st Moderna dose on 1/28/21.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Diarrhoea
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was just found dead on 4/14/21 at age 41. He was reported to be having some diarrhea, but no other suspected cause of death is evident. Patient comorbidities including chronic pain, homelessness, depression, HLD, tobacco use.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Knee arthroplasty, Knee operation, Laboratory test normal, Osteotomy
Clinical narrative: Narrative:  Patient had 1st covid moderna vaccine on 2/26/21. He had no adverse effects. He had 2nd vaccine dose on 3/26/21. He presented to podiatry appointment on 4/5 complaining of right leg and calf swelling much greater than his left and is painful for him. Podiatry ordered US which showed R Leg DVT. Patient was taken to the ER and started on rivaroxaban starter pack. Thrombophilia panel was drawn and was negative. History of complicated orthopedic trauma to his right lower extremity. Also course is complicated by multiple surgical procedures of the right knee including total knee arthroplasty and osteotomy. Patient reports being on Coumadin in the past for DVT prophylaxis, but is vehemently denying history of deep vein thrombosis. No history of COVID infection.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Ultrasound Doppler abnormal
Clinical narrative: Narrative:  Patient had 1st covid moderna vaccine on 2/26/21. He had no adverse effects. He had 2nd vaccine dose on 3/26/21. He presented to podiatry appointment on 4/5 complaining of right leg and calf swelling much greater than his left and is painful for him. Podiatry ordered US which showed R Leg DVT. Patient was taken to the ER and started on rivaroxaban starter pack. Thrombophilia panel was drawn and was negative. History of complicated orthopedic trauma to his right lower extremity. Also course is complicated by multiple surgical procedures of the right knee including total knee arthroplasty and osteotomy. Patient reports being on Coumadin in the past for DVT prophylaxis, but is vehemently denying history of deep vein thrombosis. No history of COVID infection.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Fatigue, Prostate cancer
Clinical narrative: Narrative: 85 YO male who received his 2nd dose of Moderna COVID-19 vaccine. Patient reported increased fatigue following the injection. Of note, he has chronic fatigue due to a history of encephalitis and recent diagnosis of prostate cancer but noticed a significant change after receiving the vaccines and does not feel like it has improved.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Pain, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: COVID infection after completion of COVID vaccine series 03/18 COVID vaccine dose #1 03/23 pt presented to ED with symptoms of chills, body aches, vomiting x 1, self-resolved without treatment 04/08 COVID vaccine dose  # 2 05/14 tested for COVID as part of pre-procedure screening, tested positive for  COVID remains asymptomatic
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dyspnoea, Muscle spasms, Presyncope
Clinical narrative: Narrative: She notes having developed difficulty breathing (described as increased WOB/heaviness) a/w throat and chest tightness about 10 minutes after the vaccination. She was able to ambulate w/o difficulty to an examination room down the hall from the other vaccination waiting area. The throat tightness was not a/w difficulty swallowing or swelling. It may have been a/w the feeling of spasms, but was persistent for about 3-5 minutes prior to spontaneously resolving. The chest tightness/heaviness occured along the same timeline and resolved spontaneously. It was localized to the sternum and did not radiate, was not a/w the sensation of pain. The feeling of increased WOB had greatly improved upon resolution of these sx, but was not completely resolved by the time the patient left clinic (>40minutes after vaccination). She was offered more time to rest/relax in the clinic, but felt comfortable to depart. She denied past similar reaction to other vaccine. Only known other allergy is to sulfa drugs (hives). The patient denied urticaria, flushing, swelling, confusion/disorientation, dizziness/lightheadedness, weakness, shortness of breath/wheezing, tachycardia/palpitations, nausea, abdominal cramping, or feeling the need to vomiting/have diarrhea. O: HR initially 50s on pulse ox with manual in 70s. Repeat pulse ox placement 70s BP manual 142/96 RR initially 20s, improved to ~14-15 during the examination SpO2 97-98% on RA during exam Gen: non-toxic, distress dissipated during exam, answering questions appropriately, speaking in full sentences w/o increased work of breathing HEENT: atraumatic/normocephalic, PERRL, no swelling Neck: no swelling or stridor CV: regular rate and rhythm, normal S1/S2, no murmurs Pulm: clear to auscultation bilaterally with no wheezes Ext: moves all 4 spontaneously, no edema Skin: no obvious lesions or urticaria Neuro: CN II-XII grossly intact, 5/5 strength UE and LE Psych: appropriate, thoughts linear A/P: reaction s/p 2nd Moderna vaccination. Likely vasovagal with potential concern for immediate allergic reaction component given throat and chest tightness. Both throat/chest tightness resolved w/o intervention.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: Narrative: She notes having developed difficulty breathing (described as increased WOB/heaviness) a/w throat and chest tightness about 10 minutes after the vaccination. She was able to ambulate w/o difficulty to an examination room down the hall from the other vaccination waiting area. The throat tightness was not a/w difficulty swallowing or swelling. It may have been a/w the feeling of spasms, but was persistent for about 3-5 minutes prior to spontaneously resolving. The chest tightness/heaviness occured along the same timeline and resolved spontaneously. It was localized to the sternum and did not radiate, was not a/w the sensation of pain. The feeling of increased WOB had greatly improved upon resolution of these sx, but was not completely resolved by the time the patient left clinic (>40minutes after vaccination). She was offered more time to rest/relax in the clinic, but felt comfortable to depart. She denied past similar reaction to other vaccine. Only known other allergy is to sulfa drugs (hives). The patient denied urticaria, flushing, swelling, confusion/disorientation, dizziness/lightheadedness, weakness, shortness of breath/wheezing, tachycardia/palpitations, nausea, abdominal cramping, or feeling the need to vomiting/have diarrhea. O: HR initially 50s on pulse ox with manual in 70s. Repeat pulse ox placement 70s BP manual 142/96 RR initially 20s, improved to ~14-15 during the examination SpO2 97-98% on RA during exam Gen: non-toxic, distress dissipated during exam, answering questions appropriately, speaking in full sentences w/o increased work of breathing HEENT: atraumatic/normocephalic, PERRL, no swelling Neck: no swelling or stridor CV: regular rate and rhythm, normal S1/S2, no murmurs Pulm: clear to auscultation bilaterally with no wheezes Ext: moves all 4 spontaneously, no edema Skin: no obvious lesions or urticaria Neuro: CN II-XII grossly intact, 5/5 strength UE and LE Psych: appropriate, thoughts linear A/P: reaction s/p 2nd Moderna vaccination. Likely vasovagal with potential concern for immediate allergic reaction component given throat and chest tightness. Both throat/chest tightness resolved w/o intervention.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative: Timing ERROR, too soon- 2nd dose given 4 days too early.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Narrative: She reports having experienced mild nausea and dizziness about an hour after the initial vaccination. This lasted for a few hours prior to spontaneously resolving and was not associated with other common adverse effects including vomiting, abdominal cramping or diarrhea. She was able to tolerate oral intake while having nausea.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Electrocardiogram normal, Lung opacity
Clinical narrative: None stated.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient has a PMH significant for AF, Mitral Regurgitation, Prostate Cancer, hyperlipidemia, OSA on Bipap. No death certificate noted.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash macular, Urticaria
Clinical narrative: Narrative: Monitor noticed pt. had red, blotchy welt and redness in Right arm up to Right lower neck. This is the arm where the vaccine was administered. Pt. states that recently his skin has been red in appearance. He has no history of allergies. This is his second dose of the Pfizer Covid vaccine and he had no previous reaction during the first Pfizer vaccine. Pt. denied any breathing difficulty. Vital Signs: 13:05 HR: 86, BP: 134/84, : RR 16 Temp, 37.2, O2 Sats 98%. 13:12: HR: 88. BP:  114/74 13:19 HR 87, BP: 115/74, RR 16 At 13:23 Pt. felt well enough to leave clinic on own. Encouraged patient to walk around on facility campus 10-15 minutes before returning to his car. Erythema on arm appeared decreased and improved. No meds were given.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Pharyngeal swelling
Clinical narrative: Narrative: Per chart review, pt contacted cal center approx 45 minutes after his 2nd dose of the Moderna vaccine. He reported throat swelling and chest pain that developed approx 30 minutes after vaccine dose at the hospital. RN at call center instructed him to go to nearest emergency department. Pt stated he was driving and near a hospital after he received instructions to go the nearest ED. No further information available at time of reporting.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Coordination abnormal, Full blood count, Headache, Magnetic resonance imaging, Vision blurred
Clinical narrative: Narrative: 50 yr old woman on HRT 11 days after moderna dose 2 had onset severe HA and blurry vision. also states incoordination. Sent her to ER for MRI and CBC 4/29/2021
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 89 with afib, CAD, DM, HTN, HLD. Patient not receiving much care and there is not a lot of documentation on his chart. Details surrounding his death are unknown based on chart review.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Narrative: He relates having developed swelling over the middle part of his upper lip about 3-4 hours after vaccination. This was confirmed by his wife. It began to subside by that evening and was gone the next morning. He did not apply or try any therapies. Mr. Goven denies personal or family history of angioedema. He has unknown non-severe immediate reaction PCN and reported itchiness with acetaminophen/propoxyphene in the past. While experiencing lip swelling, Mr. Goven denied: Pruritus, urticaria, flushing, difficulty breathing, palpitations, confusion/disorientation, dizziness/lightshades, weakness, nausea/vomiting, abdominal cramps and diarrhea. He also denied difficult swelling and does not think anywhere else was swollen. Referred to allergist prior to 2nd dose.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Death, Endotracheal intubation, Intensive care
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for t2dm, hyperlipidemia, CAD, HTN, Primary malignant neoplasm of right lung. Patient initially presented 4/8/21 to the ED.. Patient was admitted due to confusion and weakness and found to have respiratory failure. Patient was intubated in ICU and transition to hospice care.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for t2dm, hyperlipidemia, CAD, HTN, Primary malignant neoplasm of right lung. Patient initially presented 4/8/21 to the ED.. Patient was admitted due to confusion and weakness and found to have respiratory failure. Patient was intubated in ICU and transition to hospice care.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acquired diaphragmatic eventration, Angiogram pulmonary abnormal, C-reactive protein normal, COVID-19, Cardiomegaly
Clinical narrative: Narrative: This is a report to suggest/investigate if this PE could be COVID vaccine related vs apixaban failure related. In both cases it is a question we have and reporting is to inform of the possibility, especially in light of recent (different brand) COVID vaccine related clotting
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Procalcitonin, Pulmonary artery dilatation, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive
Clinical narrative: Narrative: This is a report to suggest/investigate if this PE could be COVID vaccine related vs apixaban failure related. In both cases it is a question we have and reporting is to inform of the possibility, especially in light of recent (different brand) COVID vaccine related clotting
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Serum ferritin normal, White blood cell count decreased
Clinical narrative: Narrative: This is a report to suggest/investigate if this PE could be COVID vaccine related vs apixaban failure related. In both cases it is a question we have and reporting is to inform of the possibility, especially in light of recent (different brand) COVID vaccine related clotting
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Oropharyngeal discomfort
Clinical narrative: Narrative:  Patient reported throat stretching and feeling of flushing after receiving first dose of COVID-19 vaccine. Symptoms lasted approximately 5 minutes and resolved after observation in an exam room. Of note, pt did not eat prior to receiving the vaccine. Left for home after observation period.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Headache
Clinical narrative: Narrative: Patient reported feeling flushed and 6/10 headache about 30 minutes after receiving first dose of COVID-19 vaccine. No hives, swelling, or other skin irritation. No dizziness, SOB, CP, N/V/D. Reports eating prior to appt and drinking water all day. Symptoms resolved about 1 hr. after vaccine administration and pt. left for home.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Haematocrit decreased, Haemoglobin decreased, Platelet count decreased, Ultrasound Doppler abnormal
Clinical narrative: Narrative:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray normal
Clinical narrative: Narrative:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip swelling, Rash
Clinical narrative: Narrative: Patient is a 61 yo F with HTN and history breast cancer, s/p lumpectomy & chemoradiation with one year remission who resents complaining of perioral numbness, lip swelling and chest rash within 15 minutes of receiving  the vaccine. No chest pain, SOB, stridor, palpitations or lateralizing weakness. - She has a latex allergy and was concerned about getting the vaccine today - Per  Pfizer, there is no latex in the vaccine vials
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  hospitalized 4-6 for hypoxemia and covid positive in setting of significant HFpEF
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dyspnoea, Fatigue, Impaired work ability
Clinical narrative: Narrative:  39 yo MALE p/w multiple complaints after taking the Covid vaccine 2 weeks ago. Patient has shortness of breath, nausea, chills, generalized weakness and fatigue. Patient states that it's hard for him to go to work because he comes  home and goes to sleep and then he can sleep at nighttime. He has sweats at  nighttime which does not keep him awake. No chest pain or abdominal pain. No fever. No headaches. No cough. No treatment given in ED and not discharged on any medications. Received the 2nd dose as scheduled.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Night sweats, Sleep disorder
Clinical narrative: Narrative:  39 yo MALE p/w multiple complaints after taking the Covid vaccine 2 weeks ago. Patient has shortness of breath, nausea, chills, generalized weakness and fatigue. Patient states that it's hard for him to go to work because he comes  home and goes to sleep and then he can sleep at nighttime. He has sweats at  nighttime which does not keep him awake. No chest pain or abdominal pain. No fever. No headaches. No cough. No treatment given in ED and not discharged on any medications. Received the 2nd dose as scheduled.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache
Clinical narrative: Narrative: Patient received first Pfizer COVID19 vaccine dose 4/10/21 and second dose 5/4/21. Presented to PCP appointment 5/10 and reported DIZZINESS, FATIGUE, HEADACHE, and LOSS OF APPETITE after second dose. No treatment documented.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram, Myalgia, Pyrexia
Clinical narrative: Narrative:  myalgias/fevers/abnormal cxr / ct requiring outside hospital admission for 3 days
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chillblains, Cough, Dyspnoea, Headache
Clinical narrative: Narrative: 30 yo F presenting to ED with two days of dry cough, body aches, generalized headache, rhinorrhea, sore throat, and sob. Pt reprots she had her COVID vaccine on Tuesday. Started feeling ill the day after (wed). Continued to feel worse today so wanted to come in to get tested to make sure she was not infeced. Pfizer vaccine. Endorses some chest tightness. On OCP. No history of DVT or PE. Decreased urine output. Tolerating po. Has not had tylenol or ibuprofen. No known fevers. +chills. +sweats. Was given APAP in ED. Discharged home.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Malaise, Oropharyngeal pain, Rhinorrhoea, Urine output decreased
Clinical narrative: Narrative: 30 yo F presenting to ED with two days of dry cough, body aches, generalized headache, rhinorrhea, sore throat, and sob. Pt reprots she had her COVID vaccine on Tuesday. Started feeling ill the day after (wed). Continued to feel worse today so wanted to come in to get tested to make sure she was not infeced. Pfizer vaccine. Endorses some chest tightness. On OCP. No history of DVT or PE. Decreased urine output. Tolerating po. Has not had tylenol or ibuprofen. No known fevers. +chills. +sweats. Was given APAP in ED. Discharged home.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: Narrative: Received J&J COVID-19 vaccine on 3/25/2021. Received Moderna COVID-19 vaccine on 4/20/2021. Error detected by nursing after vaccine was administered. No adverse effects noted at time of administration or day following. Providers were informed of extra dose.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Petechiae, Rash, Rash erythematous, Rash pruritic, Skin warm
Clinical narrative: Narrative: Patient with red, warm petchiae rash from head to toe that started approximately 12 hours after receiving 2nd COVID vaccine. Started out painful but is now itchy. CBC, BMP and UA ordered to further evaluate and make sure kidneys are not affected. Solumedrol 125 mg IM given in urgent care. Meds prescribed for home use: prednisone.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood bilirubin increased, Chest X-ray normal, Feeling abnormal, Gait inability
Clinical narrative: Narrative:  73 yo male with Parkinson's, cirrhosis, gout, HTN presenting with malaise and fever after obtaining his second CV19 vaccine yesterday and being admitted with weakness most likely related to being one day out from his 2nd CV19 vaccine. Neuro exam with no deficits except 4/5 weakness in bilateral lower extremities, so low suspicion for CVA. He is unable to ambulate on his own and required 2 people to use the bathroom. Per daughter, weakness has been progressing over last 6-9months. 100.3F on presentation, now 99F. Most likely due to CV19 vaccine. No infectious symptoms of cough, no leukocytosis, CXR without consolidations so less likely pneumonia. CV19, flu, RSV negative. No abdominal pain or TTP on exam, so low suspicion for an underlying biliary pathology that could explain the elevated total bilirubin. Most likely it is elevated due to hypoperfusion from poor PO intake after feeling poorly from his 2nd vaccine. He was admitted overnight for rehydration and discharged with resolution of acute symptoms.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoperfusion, Hypophagia, Influenza virus test negative, Malaise, Muscular weakness
Clinical narrative: Narrative:  73 yo male with Parkinson's, cirrhosis, gout, HTN presenting with malaise and fever after obtaining his second CV19 vaccine yesterday and being admitted with weakness most likely related to being one day out from his 2nd CV19 vaccine. Neuro exam with no deficits except 4/5 weakness in bilateral lower extremities, so low suspicion for CVA. He is unable to ambulate on his own and required 2 people to use the bathroom. Per daughter, weakness has been progressing over last 6-9months. 100.3F on presentation, now 99F. Most likely due to CV19 vaccine. No infectious symptoms of cough, no leukocytosis, CXR without consolidations so less likely pneumonia. CV19, flu, RSV negative. No abdominal pain or TTP on exam, so low suspicion for an underlying biliary pathology that could explain the elevated total bilirubin. Most likely it is elevated due to hypoperfusion from poor PO intake after feeling poorly from his 2nd vaccine. He was admitted overnight for rehydration and discharged with resolution of acute symptoms.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Neurological examination abnormal, Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test negative
Clinical narrative: Narrative:  73 yo male with Parkinson's, cirrhosis, gout, HTN presenting with malaise and fever after obtaining his second CV19 vaccine yesterday and being admitted with weakness most likely related to being one day out from his 2nd CV19 vaccine. Neuro exam with no deficits except 4/5 weakness in bilateral lower extremities, so low suspicion for CVA. He is unable to ambulate on his own and required 2 people to use the bathroom. Per daughter, weakness has been progressing over last 6-9months. 100.3F on presentation, now 99F. Most likely due to CV19 vaccine. No infectious symptoms of cough, no leukocytosis, CXR without consolidations so less likely pneumonia. CV19, flu, RSV negative. No abdominal pain or TTP on exam, so low suspicion for an underlying biliary pathology that could explain the elevated total bilirubin. Most likely it is elevated due to hypoperfusion from poor PO intake after feeling poorly from his 2nd vaccine. He was admitted overnight for rehydration and discharged with resolution of acute symptoms.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Narrative: Patient presented to ER with severe headache and fatigue
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Swollen tongue, Vomiting
Clinical narrative: Narrative: Pt was vaccinated with 2nd dose of Moderna on 4/29/21 around 16:06. On 4/30/21 he contacted nurse triage with c/o of waking up at 0630 with tongue swelling, difficulty swallowing, and vomiting x 3. He was instructed to to the ED. On presentation, his exam was unremarkable with no tongue swelling noted and he stated that his symptoms were decreasing. He was discharged home from the ED.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Haematoma
Clinical narrative: Narrative: The patient developed hematomas a week after the administration of the first dose vaccine.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Narrative: Patient presented to the ER due to rash after receiving the first dose of the COVID-19 vaccine. Patient tolerated second dose of the COVID-19 vaccine without any ADRs.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Joint swelling, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Narrative: here with complaint of right medial foot pain started day after he got his second Moderna Covid vaccine on 04/01 had stranging numbness and tingling to medial right foot and lips which took about a week to subside denies any associated rash nor any dyspnea/dysphagia. denies any chest tightness nor wheezing reports some swelling to medal right ankle as well the day after his covid shot which has slowly resolved. still has residual achy pain
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Narrative: here with complaint of right medial foot pain started day after he got his second Moderna Covid vaccine on 04/01 had stranging numbness and tingling to medial right foot and lips which took about a week to subside denies any associated rash nor any dyspnea/dysphagia. denies any chest tightness nor wheezing reports some swelling to medal right ankle as well the day after his covid shot which has slowly resolved. still has residual achy pain
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lip pruritus, Lip swelling
Clinical narrative: Narrative: 58 yo female with PMH of HLD, fibromyalgia, OSA, allergic rhinitis, panic disorder, depression, PTSD reported having swollen and itchy lips 2 hours post vaccine, event lasted for 30 minutes. It happened again the following day. No other symptoms reported. It was not mentioned in the record if patient took anything to treat it. Record did not mention if patient sought medical care (except for the note regarding patient's ADR). Pt also has hx of swelling of throat to kiwi, avocadoes, melons.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  I received notified from the Coroner that the patient died of natural causes on 4/22/21 which was 2 weeks after receiving the COVID vaccine.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Mobility decreased, Myalgia, Pain in extremity
Clinical narrative: Narrative: Yesterday, he received the first dose of Moderna COVID-19 vaccine. Last night he started having myalgias and fatigue. He slept for hours last night. This morning upon awakening, his generalized myalgia were so severe that he felt he could not get out of bed. Today, his left arm is so sore and painful that he can't lift his left arm about shoulder level. He has not had measured fever, chills, N/V/D, runny nose, sore throat, cough, dyspnea or abdominal pain. No change in his senses of taste or smell.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for dementia, anxiety. Per note "Resident since 2013 with progressive dementia. He has h/o PTSD, depression and anxiety disorder along with progressive dementia (possibly fronto-temporal) with associated behavioral disorder. He has been non-ambulatory , dependent on all ADL's and not recognizing family for >2yrs per wife."
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Emphysema, Hypoxia, Syncope
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient reported on 2/22/21 that he had been having recent episodes of syncope related to hypoxia. Hospice referral due to rapidly progressing emphysema on 3/17/21 after another syncope event. He later passed away on 3/20/21. Comorbidities include chronic hypoxemic respiratory failure, emphysema, pulmonary fibrosis, CAD, T2DM, HTN, HLD.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Mechanical ventilation
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Specifics regarding the patient's cause of death are not documented in chart. When contacted to schedule 2nd COVID-19 dose, wife reported on 3/11/21 patient was hospitalized on a ventilator and passed away that day. Comorbidities included T2DM, HTN, HLD, spondylosis, obesity, 50 year smoker
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Respiratory failure, SARS-CoV-2 antibody test, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient hospitalized due to COVID infection; acute hypoxic and hypercapneic respiratory failure
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Alcohol withdrawal syndrome, Cardiac failure congestive, Chronic obstructive pulmonary disease, Chronic respiratory failure
Clinical narrative: Narrative:  Per comment on ADR: maculopapular rash on both arms, about 2-3 weeks after vaccine. Note vaccine given 03/26/21. Patient seen in urgent care on 04/05/21 for shortness of breath. Patient was sent to non-agency hospital with acute on chronic respiratory failure, COPD exacerbation, CHF exacerbation, acute alcohol withdrawal, acute kidney injury. Patient seen per PCP on 04/16/21 where reaction reported; however, unable to locate documentation of rash evaluation.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Rash, Rash maculo-papular
Clinical narrative: Narrative:  Per comment on ADR: maculopapular rash on both arms, about 2-3 weeks after vaccine. Note vaccine given 03/26/21. Patient seen in urgent care on 04/05/21 for shortness of breath. Patient was sent to non-agency hospital with acute on chronic respiratory failure, COPD exacerbation, CHF exacerbation, acute alcohol withdrawal, acute kidney injury. Patient seen per PCP on 04/16/21 where reaction reported; however, unable to locate documentation of rash evaluation.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for CHF, hyperlipidemia, osteopenia, Diabetes. Pt was hospitalized with acute hypoxic respiratory failure 3/23 and sent home with hospice care.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Narrative: 3rd dose of Moderva Covid Vaccine was given prior to confirming previous doses administered.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Nausea, Pallor
Clinical narrative: Narrative: 13:30 After Patient received Covid 19 shot, he started complaining of dizziness and nausea. Pt remained AAOx4, appeared diaphoretic and pale. He denied having any chest pain, shortness of breath. Charge nurse was notified, Vital signs obtained: B/P 78/43 pulse 47 and spo2 97%RA. 13:22 Rapid response called. 13:36 Pt sitting in chair, remains AAOX4. Nursing staff and wife at side. Pt reports dizziness, lightheadedness, nausea. Denes chest pain, sob, difficulty breathing. Rapid response respiratory team arrived B/P rechecked: 91/54, pulse 56, spo2 98%RA. Pt reports he feels a little bit better. Report given to RRT nurse. Pt assessed by the RRT team and was advised to go to the ER. Patient was hesitant to go but his wife encouraged him to go and he agreed to . Patient taken to the ER via wheelchair by RRT team nursing staff. Care relinquished to RRT team nursing staff.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Injection site erythema
Clinical narrative: Narrative: Patient contacted triage line due to 3 days of fever, chills, swollen/itchy arm, headache (different than migraines) and extreme fatigue. Symptoms developed a few hours after receiving 2nd Moderna vacccine. Patient felt tired after the first vaccine, but felt well by 2nd day. Arm described as hot to touch, baseball size area of redness around injection site. No red streaks. No difficulty breathing or swelling of face, lips or tongue. Provider completed telehealth visit. Observed well demarcated erythema inferior to shoulder joint extending over bicep, redness and swelling. Large local inflammatory reaction. Recommended to continue anti-inflammatory therapy.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Local reaction, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Narrative: Patient contacted triage line due to 3 days of fever, chills, swollen/itchy arm, headache (different than migraines) and extreme fatigue. Symptoms developed a few hours after receiving 2nd Moderna vacccine. Patient felt tired after the first vaccine, but felt well by 2nd day. Arm described as hot to touch, baseball size area of redness around injection site. No red streaks. No difficulty breathing or swelling of face, lips or tongue. Provider completed telehealth visit. Observed well demarcated erythema inferior to shoulder joint extending over bicep, redness and swelling. Large local inflammatory reaction. Recommended to continue anti-inflammatory therapy.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Infrequent bowel movements
Clinical narrative: Narrative: 75 year old male reporting that since getting the Covid vaccine on March 5, he has been noticing BMs every 5-6 days. He had some initial improvement with Dulcolax, but then didn't find it to be super helpful after about 3-4 doses, causing mostly gas without significant stool output. Last took dulcolax 3 days ago. Think he has a large stool burden currently. Denies gassy pain, fever, chills,hematochezia, melena, chest pain, palpitations, URI symptoms. No treatment given in the ED. Discharged on miralax.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was hospitalized on 3/8/21 at hospital for a severe COPD exacerbation. In February 2021 he was diagnosed with lung cancer that could not be treated surgically. On 3/29/21 he was admitted to hospital with his second MI in 5 months. He later passed away there on 4/6/21. Other comorbidities include COPD requiring oxygen, MI, HTN, HLD, smoking, polysubstance abuse, homelessness.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Narrative: 34 y/o F received 2nd dose of Moderna COVID-19 Vaccine on 4/29/21 and developed upper lip swelling 15-20 min after. Patient was observed for 30min and provided with 1 dose of diphenhydramine 25mg. As of 4/30/21 airways intact, no lower lip symptoms, and upper lip still swollen, but coming down.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Malaise
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was a 59 yo female with secondary progressive MS. She was found dead in her home on 4/12/21 with no definitive cause of death reported to the agency. On 4/6/21 she was reached about receiving her second COVID-19 dose but could not come in due to her being "sick" with an undetermined illness. Her other comorbidities were primarily related to symptoms of MS including dysphagia, bladder dysfunction, and constipation. She also required a scooter for any walking.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Fluid intake reduced, General physical health deterioration, Hypophagia, Terminal state
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for advanced age (90), HF, lymphoedema, AF. Per note "The patient's condition continues to show decline he is actively dying and comfort measures are in effect. He is not eating or drinking and is had concentrated urine output. He appears to be comfortable."
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Urine abnormality, Urine output
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for advanced age (90), HF, lymphoedema, AF. Per note "The patient's condition continues to show decline he is actively dying and comfort measures are in effect. He is not eating or drinking and is had concentrated urine output. He appears to be comfortable."
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received 1st vaccine 3/11/2021 at facility, Patient declined second vaccine from facility- stated he was obtaining locally (due 4/8/2021) uncertain if he received 2nd. Notification of death on 4/9/2021 was documented as "unexpected" Unknown cause of death this is being reported because of the proximity of vaccination to death.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Biopsy skin abnormal, Insomnia, Pruritus, Rash
Clinical narrative: Narrative: Patient presents to the clinic for urgent vision on April 19 he states that he had second Moderna vaccine on 03/12/21 two days later he developed a rash. The rash started as a, "splotch on arm and is now on my bilateral upper arms, abdomen, chest, back." The rash is red slightly raised, warm to the touch, patient reports that he gets very itchy, if he takes a cold shower will feel okay about an hour later is very itchy, if he takes a cold shower will feel okay about an hour later is very itchy is not sleeping at night. No fever, or any other symptoms. Patient denies using any new lotions, detergents, soaps, cologne, shampoo. Patient has tried Benadryl, and anti-itch ointments with no effect. Provider started patient on a prednisone taper on April 19. He was seen later by Dermatolgoy and a punch biopsy done which showed rash likely due to a drug reaction. Patient had been observed for 15 minutes post injection on March 12, 2021 and did not experience any adverse reaction at that time.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash macular, Rash papular, Skin warm
Clinical narrative: Narrative: Patient presents to the clinic for urgent vision on April 19 he states that he had second Moderna vaccine on 03/12/21 two days later he developed a rash. The rash started as a, "splotch on arm and is now on my bilateral upper arms, abdomen, chest, back." The rash is red slightly raised, warm to the touch, patient reports that he gets very itchy, if he takes a cold shower will feel okay about an hour later is very itchy, if he takes a cold shower will feel okay about an hour later is very itchy is not sleeping at night. No fever, or any other symptoms. Patient denies using any new lotions, detergents, soaps, cologne, shampoo. Patient has tried Benadryl, and anti-itch ointments with no effect. Provider started patient on a prednisone taper on April 19. He was seen later by Dermatolgoy and a punch biopsy done which showed rash likely due to a drug reaction. Patient had been observed for 15 minutes post injection on March 12, 2021 and did not experience any adverse reaction at that time.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative: positive COVID test with mild symptoms treated at home after patient was fully vaccinated
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Dyspnoea, Fatigue, Hypercapnia
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for tobacco use, Diabetes, HTN, chronic obstructive lung disease, hypercholesterolemia, primary malignant neoplasm of lung. Pt was 76 years of age. Admitted on 4/13 for HYPERCAONEIC RESPIRATORY FALIURE. Per note on 4/13 ". Patient is a 76-year-old gentleman with chronic respiratory failure on home oxygen, severe COPD (FEV1 0.6 L), history of lung cancer status post right middle and lower lobe lobectomies in 2008, history of pulmonary embolism in July 2015, diabetes, newly detected enlarging right upper lobe nodule concerning for bronchogenic carcinoma who presents with increasing cough, dyspnea and fatigue. He was noted to be hypoxic/hypercapnic in the ED, placed on BiPAP and transferred to the MICU." Discharged 4/15 under the care of his son.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Intensive care, Positive airway pressure therapy, Respiratory failure
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has a PMH significant for tobacco use, Diabetes, HTN, chronic obstructive lung disease, hypercholesterolemia, primary malignant neoplasm of lung. Pt was 76 years of age. Admitted on 4/13 for HYPERCAONEIC RESPIRATORY FALIURE. Per note on 4/13 ". Patient is a 76-year-old gentleman with chronic respiratory failure on home oxygen, severe COPD (FEV1 0.6 L), history of lung cancer status post right middle and lower lobe lobectomies in 2008, history of pulmonary embolism in July 2015, diabetes, newly detected enlarging right upper lobe nodule concerning for bronchogenic carcinoma who presents with increasing cough, dyspnea and fatigue. He was noted to be hypoxic/hypercapnic in the ED, placed on BiPAP and transferred to the MICU." Discharged 4/15 under the care of his son.